The high expression rate of HE4 in moderately and poorly differentiated carcinoma was 58.3 % (14/24) and 48.8 % (21/43), respectively, which was significantly higher than well-differentiated cancer (17.6 % [3/17]; both p < 0.05) (Table 2). Here, WFDC2 is linked to cancer.